0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Editing Therapy Market Research Report 2026
Published Date: 2026-03-31
|
Report Code: QYRE-Auto-31I17252
Home | Market Reports
Global Gene Editing Therapy Market Research Report 2024
BUY CHAPTERS

Global Gene Editing Therapy Market Research Report 2026

Code: QYRE-Auto-31I17252
Report
2026-03-31
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gene Editing Therapy Market

The global Gene Editing Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The North American market for Gene Editing Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Gene Editing Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Gene Editing Therapy in Thalassemia is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Gene Editing Therapy include CRISPR Therapeutics, Beam Therapeutics, Editas Medicine, Verve Therapeutics, Bluebird Bio, Intellia Therapeutics, Vertex Pharmaceuticals, Caribou Biosciences, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Gene Editing Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gene Editing Therapy. The Gene Editing Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Gene Editing Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Gene Editing Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Gene Editing Therapy Market Report

Report Metric Details
Report Name Gene Editing Therapy Market
Segment by Type
  • In Vivo Gene Editing
  • In Vitro Gene Editing
Segment by Application
  • Thalassemia
  • Cancer
  • Cystic Fibrosis
  • Muscular Dystrophy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CRISPR Therapeutics, Beam Therapeutics, Editas Medicine, Verve Therapeutics, Bluebird Bio, Intellia Therapeutics, Vertex Pharmaceuticals, Caribou Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Gene Editing Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Editing Therapy Market report?

Ans: The main players in the Gene Editing Therapy Market are CRISPR Therapeutics, Beam Therapeutics, Editas Medicine, Verve Therapeutics, Bluebird Bio, Intellia Therapeutics, Vertex Pharmaceuticals, Caribou Biosciences

What are the Application segmentation covered in the Gene Editing Therapy Market report?

Ans: The Applications covered in the Gene Editing Therapy Market report are Thalassemia, Cancer, Cystic Fibrosis, Muscular Dystrophy, Others

What are the Type segmentation covered in the Gene Editing Therapy Market report?

Ans: The Types covered in the Gene Editing Therapy Market report are In Vivo Gene Editing, In Vitro Gene Editing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Editing Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 In Vivo Gene Editing
1.2.3 In Vitro Gene Editing
1.3 Market by Application
1.3.1 Global Gene Editing Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Thalassemia
1.3.3 Cancer
1.3.4 Cystic Fibrosis
1.3.5 Muscular Dystrophy
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Editing Therapy Market Perspective (2021–2032)
2.2 Global Gene Editing Therapy Growth Trends by Region
2.2.1 Global Gene Editing Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Gene Editing Therapy Historic Market Size by Region (2021–2026)
2.2.3 Gene Editing Therapy Forecasted Market Size by Region (2027–2032)
2.3 Gene Editing Therapy Market Dynamics
2.3.1 Gene Editing Therapy Industry Trends
2.3.2 Gene Editing Therapy Market Drivers
2.3.3 Gene Editing Therapy Market Challenges
2.3.4 Gene Editing Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Editing Therapy Players by Revenue
3.1.1 Global Top Gene Editing Therapy Players by Revenue (2021–2026)
3.1.2 Global Gene Editing Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Gene Editing Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Gene Editing Therapy Revenue
3.4 Global Gene Editing Therapy Market Concentration Ratio
3.4.1 Global Gene Editing Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Editing Therapy Revenue in 2025
3.5 Global Key Players of Gene Editing Therapy Head Offices and Areas Served
3.6 Global Key Players of Gene Editing Therapy, Products and Applications
3.7 Global Key Players of Gene Editing Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Gene Editing Therapy Breakdown Data by Type
4.1 Global Gene Editing Therapy Historic Market Size by Type (2021–2026)
4.2 Global Gene Editing Therapy Forecasted Market Size by Type (2027–2032)
5 Gene Editing Therapy Breakdown Data by Application
5.1 Global Gene Editing Therapy Historic Market Size by Application (2021–2026)
5.2 Global Gene Editing Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Gene Editing Therapy Market Size (2021–2032)
6.2 North America Gene Editing Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Gene Editing Therapy Market Size by Country (2021–2026)
6.4 North America Gene Editing Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Editing Therapy Market Size (2021–2032)
7.2 Europe Gene Editing Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Gene Editing Therapy Market Size by Country (2021–2026)
7.4 Europe Gene Editing Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Gene Editing Therapy Market Size (2021–2032)
8.2 Asia-Pacific Gene Editing Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Gene Editing Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Gene Editing Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Gene Editing Therapy Market Size (2021–2032)
9.2 Latin America Gene Editing Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Gene Editing Therapy Market Size by Country (2021–2026)
9.4 Latin America Gene Editing Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Editing Therapy Market Size (2021–2032)
10.2 Middle East & Africa Gene Editing Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Gene Editing Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Gene Editing Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CRISPR Therapeutics
11.1.1 CRISPR Therapeutics Company Details
11.1.2 CRISPR Therapeutics Business Overview
11.1.3 CRISPR Therapeutics Gene Editing Therapy Introduction
11.1.4 CRISPR Therapeutics Revenue in Gene Editing Therapy Business (2021–2026)
11.1.5 CRISPR Therapeutics Recent Development
11.2 Beam Therapeutics
11.2.1 Beam Therapeutics Company Details
11.2.2 Beam Therapeutics Business Overview
11.2.3 Beam Therapeutics Gene Editing Therapy Introduction
11.2.4 Beam Therapeutics Revenue in Gene Editing Therapy Business (2021–2026)
11.2.5 Beam Therapeutics Recent Development
11.3 Editas Medicine
11.3.1 Editas Medicine Company Details
11.3.2 Editas Medicine Business Overview
11.3.3 Editas Medicine Gene Editing Therapy Introduction
11.3.4 Editas Medicine Revenue in Gene Editing Therapy Business (2021–2026)
11.3.5 Editas Medicine Recent Development
11.4 Verve Therapeutics
11.4.1 Verve Therapeutics Company Details
11.4.2 Verve Therapeutics Business Overview
11.4.3 Verve Therapeutics Gene Editing Therapy Introduction
11.4.4 Verve Therapeutics Revenue in Gene Editing Therapy Business (2021–2026)
11.4.5 Verve Therapeutics Recent Development
11.5 Bluebird Bio
11.5.1 Bluebird Bio Company Details
11.5.2 Bluebird Bio Business Overview
11.5.3 Bluebird Bio Gene Editing Therapy Introduction
11.5.4 Bluebird Bio Revenue in Gene Editing Therapy Business (2021–2026)
11.5.5 Bluebird Bio Recent Development
11.6 Intellia Therapeutics
11.6.1 Intellia Therapeutics Company Details
11.6.2 Intellia Therapeutics Business Overview
11.6.3 Intellia Therapeutics Gene Editing Therapy Introduction
11.6.4 Intellia Therapeutics Revenue in Gene Editing Therapy Business (2021–2026)
11.6.5 Intellia Therapeutics Recent Development
11.7 Vertex Pharmaceuticals
11.7.1 Vertex Pharmaceuticals Company Details
11.7.2 Vertex Pharmaceuticals Business Overview
11.7.3 Vertex Pharmaceuticals Gene Editing Therapy Introduction
11.7.4 Vertex Pharmaceuticals Revenue in Gene Editing Therapy Business (2021–2026)
11.7.5 Vertex Pharmaceuticals Recent Development
11.8 Caribou Biosciences
11.8.1 Caribou Biosciences Company Details
11.8.2 Caribou Biosciences Business Overview
11.8.3 Caribou Biosciences Gene Editing Therapy Introduction
11.8.4 Caribou Biosciences Revenue in Gene Editing Therapy Business (2021–2026)
11.8.5 Caribou Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Gene Editing Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of In Vivo Gene Editing
 Table 3. Key Players of In Vitro Gene Editing
 Table 4. Global Gene Editing Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Gene Editing Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Gene Editing Therapy Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Gene Editing Therapy Market Share by Region (2021–2026)
 Table 8. Global Gene Editing Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Gene Editing Therapy Market Share by Region (2027–2032)
 Table 10. Gene Editing Therapy Market Trends
 Table 11. Gene Editing Therapy Market Drivers
 Table 12. Gene Editing Therapy Market Challenges
 Table 13. Gene Editing Therapy Market Restraints
 Table 14. Global Gene Editing Therapy Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Gene Editing Therapy Market Share by Players (2021–2026)
 Table 16. Global Top Gene Editing Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Gene Editing Therapy Revenue, 2025
 Table 17. Ranking of Global Top Gene Editing Therapy Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Gene Editing Therapy Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Gene Editing Therapy, Headquarters and Area Served
 Table 20. Global Key Players of Gene Editing Therapy, Products and Applications
 Table 21. Global Key Players of Gene Editing Therapy, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Gene Editing Therapy Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Gene Editing Therapy Revenue Market Share by Type (2021–2026)
 Table 25. Global Gene Editing Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Gene Editing Therapy Revenue Market Share by Type (2027–2032)
 Table 27. Global Gene Editing Therapy Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Gene Editing Therapy Revenue Market Share by Application (2021–2026)
 Table 29. Global Gene Editing Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Gene Editing Therapy Revenue Market Share by Application (2027–2032)
 Table 31. North America Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Gene Editing Therapy Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Gene Editing Therapy Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Gene Editing Therapy Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Gene Editing Therapy Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Gene Editing Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Gene Editing Therapy Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Gene Editing Therapy Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Gene Editing Therapy Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Gene Editing Therapy Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Gene Editing Therapy Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Gene Editing Therapy Market Size by Country (US$ Million), 2027–2032
 Table 46. CRISPR Therapeutics Company Details
 Table 47. CRISPR Therapeutics Business Overview
 Table 48. CRISPR Therapeutics Gene Editing Therapy Product
 Table 49. CRISPR Therapeutics Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
 Table 50. CRISPR Therapeutics Recent Development
 Table 51. Beam Therapeutics Company Details
 Table 52. Beam Therapeutics Business Overview
 Table 53. Beam Therapeutics Gene Editing Therapy Product
 Table 54. Beam Therapeutics Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
 Table 55. Beam Therapeutics Recent Development
 Table 56. Editas Medicine Company Details
 Table 57. Editas Medicine Business Overview
 Table 58. Editas Medicine Gene Editing Therapy Product
 Table 59. Editas Medicine Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
 Table 60. Editas Medicine Recent Development
 Table 61. Verve Therapeutics Company Details
 Table 62. Verve Therapeutics Business Overview
 Table 63. Verve Therapeutics Gene Editing Therapy Product
 Table 64. Verve Therapeutics Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
 Table 65. Verve Therapeutics Recent Development
 Table 66. Bluebird Bio Company Details
 Table 67. Bluebird Bio Business Overview
 Table 68. Bluebird Bio Gene Editing Therapy Product
 Table 69. Bluebird Bio Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
 Table 70. Bluebird Bio Recent Development
 Table 71. Intellia Therapeutics Company Details
 Table 72. Intellia Therapeutics Business Overview
 Table 73. Intellia Therapeutics Gene Editing Therapy Product
 Table 74. Intellia Therapeutics Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
 Table 75. Intellia Therapeutics Recent Development
 Table 76. Vertex Pharmaceuticals Company Details
 Table 77. Vertex Pharmaceuticals Business Overview
 Table 78. Vertex Pharmaceuticals Gene Editing Therapy Product
 Table 79. Vertex Pharmaceuticals Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
 Table 80. Vertex Pharmaceuticals Recent Development
 Table 81. Caribou Biosciences Company Details
 Table 82. Caribou Biosciences Business Overview
 Table 83. Caribou Biosciences Gene Editing Therapy Product
 Table 84. Caribou Biosciences Revenue in Gene Editing Therapy Business (US$ Million), 2021–2026
 Table 85. Caribou Biosciences Recent Development
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources
 Table 89. Authors List of This Report


List of Figures
 Figure 1. Gene Editing Therapy Picture
 Figure 2. Global Gene Editing Therapy Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Gene Editing Therapy Market Share by Type: 2025 vs 2032
 Figure 4. In Vivo Gene Editing Features
 Figure 5. In Vitro Gene Editing Features
 Figure 6. Global Gene Editing Therapy Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Gene Editing Therapy Market Share by Application: 2025 vs 2032
 Figure 8. Thalassemia Case Studies
 Figure 9. Cancer Case Studies
 Figure 10. Cystic Fibrosis Case Studies
 Figure 11. Muscular Dystrophy Case Studies
 Figure 12. Others Case Studies
 Figure 13. Gene Editing Therapy Report Years Considered
 Figure 14. Global Gene Editing Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Gene Editing Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Gene Editing Therapy Market Share by Region: 2025 vs 2032
 Figure 17. Global Gene Editing Therapy Market Share by Players in 2025
 Figure 18. Global Gene Editing Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Gene Editing Therapy Revenue in 2025
 Figure 20. North America Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Gene Editing Therapy Market Share by Country (2021–2032)
 Figure 22. United States Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Gene Editing Therapy Market Share by Country (2021–2032)
 Figure 26. Germany Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Gene Editing Therapy Market Share by Region (2021–2032)
 Figure 34. China Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Gene Editing Therapy Market Share by Country (2021–2032)
 Figure 42. Mexico Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Gene Editing Therapy Market Share by Country (2021–2032)
 Figure 46. Israel Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Gene Editing Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. CRISPR Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
 Figure 50. Beam Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
 Figure 51. Editas Medicine Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
 Figure 52. Verve Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
 Figure 53. Bluebird Bio Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
 Figure 54. Intellia Therapeutics Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
 Figure 55. Vertex Pharmaceuticals Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
 Figure 56. Caribou Biosciences Revenue Growth Rate in Gene Editing Therapy Business (2021–2026)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String